Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACR
2251
ACRES Commercial Realty
ACR
$102M
| $2.11M | ﹤0.01% |
61,968
-13,294
| -18% | -$454K |
|
2252
Primerica
PRI
$9.65B
| $2.11M | ﹤0.01% |
16,600
-67,700
| -80% | -$8.17M |
|
|
CRHM
2253
DELISTED
CRH Medical Corporation
CRHM
| $2.11M | ﹤0.01% |
685,600
+15,900
| +2% | +$47.2K |
|
2254
RCM Technologies
RCMT
$248M
| $2.11M | ﹤0.01% |
703,562
-10,403
| -1% | -$33.4K |
|
2255
Midland States Bancorp
MSBI
$693M
| $2.11M | ﹤0.01% |
81,000
+26,500
| +49% | +$695K |
|
2256
MBIA
MBI
$264M
| $2.11M | ﹤0.01% |
+228,374
| New | +$2.14M |
|
2257
Comscore
SCOR
$93.6M
| $2.1M | ﹤0.01% |
54,977
+33,477
| +156% | +$1.93M |
|
|
IEC
2258
DELISTED
IEC Electronics Corp.
IEC
| $2.09M | ﹤0.01% |
302,821
-43,162
| -12% | -$276K |
|
2259
Werner Enterprises
WERN
$2.33B
| $2.09M | ﹤0.01% |
59,163
+52,100
| +738% | +$1.7M |
|
2260
LSB Industries
LXU
$737M
| $2.08M | ﹤0.01% |
523,249
+107,900
| +26% | +$385K |
|
|
SNV
2261
DELISTED
Synovus
SNV
| $2.08M | ﹤0.01% |
58,300
+14,200
| +32% | +$509K |
|
|
PDCO
2262
DELISTED
Patterson Companies, Inc.
PDCO
| $2.08M | ﹤0.01% |
116,504
-188,800
| -62% | -$3.53M |
|
|
FFWM
2263
DELISTED
First Foundation Inc
FFWM
| $2.07M | ﹤0.01% |
135,765
+20,500
| +18% | +$295K |
|
|
MINI
2264
DELISTED
Mobile Mini Inc
MINI
| $2.07M | ﹤0.01% |
56,070
-367,300
| -87% | -$12M |
|
|
ERUS
2265
DELISTED
iShares MSCI Russia ETF
ERUS
| $2.07M | ﹤0.01% |
53,100
+26,200
| +97% | +$1.01M |
|
|
EIGR
2266
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $2.06M | ﹤0.01% |
6,711
-3,243
| -33% | -$1.05M |
|
2267
Alphatec Holdings
ATEC
$1.51B
| $2.06M | ﹤0.01% |
409,987
+133,200
| +48% | +$692K |
|
|
AZRE
2268
DELISTED
Azure Power Global Limited
AZRE
| $2.06M | ﹤0.01% |
171,462
+7,301
| +4% | +$78.9K |
|
|
GMLP
2269
DELISTED
Golar LNG Partners LP
GMLP
| $2.06M | ﹤0.01% |
214,600
+89,900
| +72% | +$951K |
|
|
EGRX
2270
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2.05M | ﹤0.01% |
+36,300
| New | +$2.04M |
|
2271
Douglas Dynamics
PLOW
$976M
| $2.04M | ﹤0.01% |
45,800
+15,000
| +49% | +$628K |
|
2272
Saic
SAIC
$5.36B
| $2.04M | ﹤0.01% |
+23,350
| New | +$1.99M |
|
|
TRVN
2273
DELISTED
Trevena, Inc.
TRVN
| $2.04M | ﹤0.01% |
3,375
+289
| +9% | +$170K |
|
|
AMWD
2274
DELISTED
American Woodmark
AMWD
| $2.04M | ﹤0.01% |
+22,901
| New | +$1.89M |
|
|
NPKI
2275
NPK International
NPKI
$1.21B
| $2.03M | ﹤0.01% |
266,900
-225,600
| -46% | -$1.6M |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.